Vestibular Schwannoma
📧 Sign up to get email alerts when something new happens for Vestibular Schwannoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma [Phase 1, Phase 2]
This document describes an ongoing Phase 1/2 clinical trial testing an anti-VEGF gene therapy for vestibular schwannoma, with recruitment st…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Long-term follow-up study of an investigational AAVAnc80-antiVEGF gene therapy for vestibular schwannoma is underway. Enrollment is by invit…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures [EARLY_Phase 1]
This document describes a NOT_YET_RECRUITING Phase 1 pilot study evaluating Panitumumab-IRDye800 as an optical imaging agent to detect intra…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas [NA]
A clinical trial is evaluating pre-treatment vestibular physical therapy rehabilitation for patients with vestibular schwannoma. Recruitment…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]
Phase 2 clinical trial of crizotinib in children and adults with Neurofibromatosis type 2 and progressive vestibular schwannomas has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Vestibular Schwannoma Organoids
The clinical trial investigating vestibular schwannoma organoids has completed, with Maastricht Radiation Oncology listed as the sponsor.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma [NA]
This clinical trial is investigating a vestibular rehabilitation protocol for patients with unilateral vestibular schwannoma and is currentl…
-
CLINICAL_TRIALS withdrawal · 2026-01-13Clinical Trial Update: Role of ChatGPT in Vestibular Schwannoma Management [NA]
A clinical trial investigating the use of ChatGPT in vestibular schwannoma management has been withdrawn.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) [Phase 2]
This update covers an ongoing Phase 2 clinical trial (INTUITT-NF2) evaluating targeted therapies for NF2-related schwannomatosis. The study …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of Aspirin in Patients With Vestibular Schwannoma [Phase 2]
Phase 2 clinical trial update for aspirin in vestibular schwannoma patients; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Measuring Vestibular Organ Function With Weak Alternating Current Stimulation [NA]
Aalto University is conducting a clinical trial to measure vestibular organ function using weak alternating current stimulation; the study i…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: StableEyes With Active Neurofeedback [NA]
A Johns Hopkins University study titled StableEyes With Active Neurofeedback is currently recruiting for vestibular disorders, including ves…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma [Phase 2]
This Phase 2 clinical trial update reports on hearing outcomes after fractionated proton radiation therapy for vestibular schwannoma.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas [NA]
Clinical trial evaluating diffusion tensor tractography to define facial nerve position in vestibular schwannomas has completed. The study i…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma [NA]
This clinical trial update describes an active fMRI study to map activation of vestibular processing centers in patients with Vestibular Sch…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients [Phase 3]
Phase 3 clinical trial evaluating steroids to protect facial nerve function after vestibular schwannoma surgery; status is not yet recruitin…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: The Use of Virtual Reality in Rehabilitation in Patients After Vestibular Schwannoma Surgery. [NA]
A Czech clinical trial from Charles University is evaluating virtual reality-based rehabilitation for patients with vestibular dysfunction f…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit [NA]
An ongoing clinical trial from Hospices Civils de Lyon investigates early rehabilitation using the Head Impulse Test for acute vestibular de…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
-
CLINICAL_TRIALS withdrawal · 2025-04-16Clinical Trial Update: Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma [NA]
A clinical trial (NCT04196933) evaluating vestibular compensation after intervention for vestibular schwannoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma [Phase 1]
Phase 1 trial of super-selective intra-arterial bevacizumab (Avastin) for vestibular schwannoma has been suspended.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. [NA]
A clinical trial evaluating radiosurgery versus observation for vestibular schwannoma (V-REX) has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy [NA]
The clinical trial update reports termination of a study evaluating longitudinal recovery of head and trunk control in people with acquired …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: CI Following VS Removal or Labyrinthectomy [NA]
A recruiting clinical trial at Ohio State University is evaluating cochlear implantation after vestibular schwannoma removal or labyrinthect…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Quality of Life and Decisional Regret in Patients Affected by Acoustic Neuroma
This clinical trial update describes a study evaluating quality of life outcomes and decisional regret in patients with acoustic neuroma, cu…